People

Die angesagtesten Promis bei uns. Die neuesten EXKLUSIVEN Bilder nur für registrierte User!

News

Aktuelles Tagesgeschehen rund um den Globus.

Features

Skurriles, Spassiges und Absurdes aus aller Welt.

Styling

Trends aus Fashion und Design.

Portrait

Premium Portraitfotografie.

Reportage

Stories, Facts und Hintergrund, alles im Bild.

Creative

Auf der Suche nach mehr? Prisma by Dukas.

Dukas Bildagentur
request@dukas.ch
+41 44 298 50 00

Ihre Suche nach:

11 Ergebnis(se) in 0.11 s

  • FDA approves deep-brain stimulation treatment for Parkinsons patients
    DUKAS_183263420_POL
    FDA approves deep-brain stimulation treatment for Parkinsons patients
    3/24/2025 - San Francisco, California, USA: Pat Wright, left, watches her partner Parkinson’s patient Deb Zeyen, former VP in Marketing and Internet Development for CBS Television Network, as she demonstrates her motor skills during her treatment with neurologist Simon Little, UCSF, at the UCSF Weill Institute in San Francisco on Monday, March 24, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
    ©San Francisco Chronicle/Yalonda M. James

     

  • FDA approves deep-brain stimulation treatment for Parkinsons patients
    DUKAS_183263419_POL
    FDA approves deep-brain stimulation treatment for Parkinsons patients
    3/24/2025 - San Francisco, California, USA: Parkinson’s patient Deb Zeyen, former VP in Marketing and Internet Development for CBS Television Network, walks in a hallway to demonstrate her motor skills during her treatment with neurologist Simon Little, UCSF, right, at the UCSF Weill Institute in San Francisco on Monday, March 24, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
    ©San Francisco Chronicle/Yalonda M. James

     

  • FDA approves deep-brain stimulation treatment for Parkinsons patients
    DUKAS_183263418_POL
    FDA approves deep-brain stimulation treatment for Parkinsons patients
    3/24/2025 - San Francisco, California, USA: Nurse practitioner Monica Volz, with UCSF’s deep-brain stimulation program, works with neurologist Simon Little, UCSF, during a treatment with Parkinson’s patient Deb Zeyen, both not pictured, former VP in Marketing and Internet Development for CBS Television Network, at the UCSF Weill Institute in San Francisco on Monday, March 24, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
    ©San Francisco Chronicle/Yalonda M. James

     

  • FDA approves deep-brain stimulation treatment for Parkinsons patients
    DUKAS_183263417_POL
    FDA approves deep-brain stimulation treatment for Parkinsons patients
    3/24/2025 - San Francisco, California, USA: Parkinson’s patient Deb Zeyen, former VP in Marketing and Internet Development for CBS Television Network, attends her treatment with neurologist Simon Little, UCSF, at the UCSF Weill Institute in San Francisco on Monday, March 24, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
    ©San Francisco Chronicle/Yalonda M. James

     

  • FDA approves deep-brain stimulation treatment for Parkinsons patients
    DUKAS_183263400_POL
    FDA approves deep-brain stimulation treatment for Parkinsons patients
    3/24/2025 - San Francisco, California, USA: Parkinson’s patient Deb Zeyen, former VP in Marketing and Internet Development for CBS Television Network, walks in a hallway to demonstrate her motor skills during her treatment with neurologist Simon Little, UCSF, right, at the UCSF Weill Institute in San Francisco on Monday, March 24, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
    ©San Francisco Chronicle/Yalonda M. James

     

  • FDA approves deep-brain stimulation treatment for Parkinsons patients
    DUKAS_183263399_POL
    FDA approves deep-brain stimulation treatment for Parkinsons patients
    3/24/2025 - San Francisco, California, USA: Parkinson’s patient Deb Zeyen, former VP in Marketing and Internet Development for CBS Television Network, demonstrates her motor skills during her treatment with neurologist Simon Little, UCSF, at the UCSF Weill Institute in San Francisco on Monday, March 24, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
    ©San Francisco Chronicle/Yalonda M. James

     

  • FDA approves deep-brain stimulation treatment for Parkinsons patients
    DUKAS_183263398_POL
    FDA approves deep-brain stimulation treatment for Parkinsons patients
    3/24/2025 - San Francisco, California, USA: Parkinson’s patient Deb Zeyen, former VP in Marketing and Internet Development for CBS Television Network, walks in a hallway to demonstrate her motor skills during her treatment with neurologist Simon Little, UCSF, right, at the UCSF Weill Institute in San Francisco on Monday, March 24, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
    ©San Francisco Chronicle/Yalonda M. James

     

  • FDA approves deep-brain stimulation treatment for Parkinsons patients
    DUKAS_183263394_POL
    FDA approves deep-brain stimulation treatment for Parkinsons patients
    3/24/2025 - San Francisco, California, USA: Parkinson’s patient Deb Zeyen, former VP in Marketing and Internet Development for CBS Television Network, works on her motor skills during her treatment with neurologist Simon Little, UCSF, at the UCSF Weill Institute in San Francisco on Monday, March 24, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
    ©San Francisco Chronicle/Yalonda M. James

     

  • FDA approves deep-brain stimulation treatment for Parkinsons patients
    DUKAS_183263392_POL
    FDA approves deep-brain stimulation treatment for Parkinsons patients
    3/24/2025 - San Francisco, California, USA: Parkinson’s patient Deb Zeyen, left, former VP in Marketing and Internet Development for CBS Television Network, attends her treatment with neurologist Simon Little, UCSF, and nurse practitioner Monica Volz, with UCSF’s deep-brain stimulation program, at the UCSF Weill Institute in San Francisco on Monday, March 24, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
    ©San Francisco Chronicle/Yalonda M. James

     

  • FDA approves deep-brain stimulation treatment for Parkinsons patients
    DUKAS_183263390_POL
    FDA approves deep-brain stimulation treatment for Parkinsons patients
    3/24/2025 - San Francisco, California, USA: Parkinson’s patient Deb Zeyen, former VP in Marketing and Internet Development for CBS Television Network, attends her treatment with neurologist Simon Little, UCSF, at the UCSF Weill Institute in San Francisco on Monday, March 24, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
    ©San Francisco Chronicle/Yalonda M. James

     

  • FDA approves deep-brain stimulation treatment for Parkinsons patients
    DUKAS_183263368_POL
    FDA approves deep-brain stimulation treatment for Parkinsons patients
    3/24/2025 - San Francisco, California, USA: Parkinson’s patient Deb Zeyen, left, former VP in Marketing and Internet Development for CBS Television Network, drinks water during her treatment with neurologist Simon Little, UCSF, at the UCSF Weill Institute in San Francisco on Monday, March 24, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
    ©San Francisco Chronicle/Yalonda M. James